KK
RMD icon

KLP Kapitalforvaltning’s ResMed RMD Stock Holding History

KLP Kapitalforvaltning’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2M Buy
129,210
+2,200
+2% +$456K 0.08% 231
2026
Q1 		$28.5M Buy
127,010
+3,360
+3% +$837K 0.11% 180
2025
Q4 		$29.8M Buy
123,650
+32,400
+36% +$8.29M 0.12% 161
2025
Q3 		$25M Hold
91,250
– – 0.1% 193
2025
Q2 		$23.5M Buy
91,250
+2,000
+2% +$477K 0.1% 196
2025
Q1 		$20M Hold
89,250
– – 0.1% 209
2024
Q4 		$20.4M Buy
+89,250
New +$21.5M 0.1% 202

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

KLP Kapitalforvaltning's RMD Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its ResMed (RMD) stake by 1.7% in Q2 2026, buying an estimated $456K and bringing the position to 129,210 shares worth $25.2M. The position accounts for 0.08% of the portfolio, ranked #231.

KLP Kapitalforvaltning first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $29.8M in Q4 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • KLP Kapitalforvaltning held 129,210 shares of ResMed worth $25.2M as of Q2 2026.
  • KLP Kapitalforvaltning bought 2,200 ResMed shares in Q2 2026, an estimated $456K.
  • ResMed made up 0.08% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #231 holding.
  • KLP Kapitalforvaltning first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's ResMed position peaked at $29.8M in Q4 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.